[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients].

Abstract

Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients Activated thrombocytes and their aggregation into a thrombus play a decisive role in the pathogenesis of the acute coronary syndrome. Glycoprotein (GP) IIb/IIIa receptor antagonists block the binding of… (More)

Topics

Cite this paper

@article{Mnzel2006PathogenesisAT, title={[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients].}, author={Thomas F. M{\"u}nzel and Frits Post}, journal={Deutsche medizinische Wochenschrift}, year={2006}, volume={131 47 Suppl 7}, pages={S215-8} }